POWRESI Trademark

Trademark Overview


On Friday, September 29, 2017, a trademark application was filed for POWRESI with the United States Patent and Trademark Office. The USPTO has given the POWRESI trademark a serial number of 79226083. The federal status of this trademark filing is REGISTERED as of Tuesday, May 29, 2018. This trademark is owned by Astellas Pharma Inc.. The POWRESI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, oncological, ophthalmological, peripheral nervous system, psychiatric, renal, respiratory, urogenital, urological, osteopathic, hematological, pulmonary and viral diseases and disorders; pharmaceutical preparations for the treatment pain and diabetes; pharmaceutical preparations for use in regenerative medicine; pharmaceutical preparations, namely, antibacterial preparations, antifungal preparations, antiviral preparations, dermatological preparations, immunosuppressants, and tissue repair preparations; vaccines
powresi

General Information


Serial Number79226083
Word MarkPOWRESI
Filing DateFriday, September 29, 2017
Status700 - REGISTERED
Status DateTuesday, May 29, 2018
Registration Number5478119
Registration DateTuesday, May 29, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 13, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, oncological, ophthalmological, peripheral nervous system, psychiatric, renal, respiratory, urogenital, urological, osteopathic, hematological, pulmonary and viral diseases and disorders; pharmaceutical preparations for the treatment pain and diabetes; pharmaceutical preparations for use in regenerative medicine; pharmaceutical preparations, namely, antibacterial preparations, antifungal preparations, antiviral preparations, dermatological preparations, immunosuppressants, and tissue repair preparations; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 7, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Friday, February 2, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, February 1, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, February 13, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, July 10, 2018FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, February 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 7, 2018ASSIGNED TO EXAMINER
Wednesday, February 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2018NOTICE OF PUBLICATION
Tuesday, March 13, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 29, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, June 28, 2018GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Monday, July 9, 2018FINAL DISPOSITION PROCESSED
Friday, July 30, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 3, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 3, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, July 27, 2018NOTIFICATION PROCESSED BY IB
Saturday, June 25, 2022NEW REPRESENTATIVE AT IB RECEIVED
Monday, May 29, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, July 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 9, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS